383 related articles for article (PubMed ID: 20392324)
1. Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionals.
Koopmanschap MA; Stolk EA; Koolman X
Int J Technol Assess Health Care; 2010 Apr; 26(2):198-204. PubMed ID: 20392324
[TBL] [Abstract][Full Text] [Related]
2. Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency.
Mirelman A; Mentzakis E; Kinter E; Paolucci F; Fordham R; Ozawa S; Ferraz M; Baltussen R; Niessen LW
Value Health; 2012 May; 15(3):534-9. PubMed ID: 22583464
[TBL] [Abstract][Full Text] [Related]
3. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
[TBL] [Abstract][Full Text] [Related]
4. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
[TBL] [Abstract][Full Text] [Related]
5. Primary care physicians in Israel: self-perception of their role in the healthcare system and policy makers' and patients' perception of them as gatekeepers.
Tabenkin H; Gross R; Greenberg SB; Steinmetz D; Elhayany A
Isr Med Assoc J; 2001 Dec; 3(12):893-7. PubMed ID: 11794909
[TBL] [Abstract][Full Text] [Related]
6. Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? A Discrete Choice Experiment Among Dutch Healthcare Decision Makers.
Enzing JJ; Himmler S; Knies S; Brouwer WBF
Value Health; 2022 Feb; 25(2):222-229. PubMed ID: 35094795
[TBL] [Abstract][Full Text] [Related]
7. Health technology assessment: research trends and future priorities in Europe.
Nielsen CP; Funch TM; Kristensen FB
J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
[TBL] [Abstract][Full Text] [Related]
8. A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory study.
Mentzakis E; Stefanowska P; Hurley J
Health Econ Policy Law; 2011 Jul; 6(3):405-33. PubMed ID: 21205401
[TBL] [Abstract][Full Text] [Related]
9. Attitudes towards priority-setting and rationing in healthcare -- an exploratory survey of Swedish medical students.
Omar F; Tinghög G; Tinghög P; Carlsson P
Scand J Public Health; 2009 Mar; 37(2):122-30. PubMed ID: 19141543
[TBL] [Abstract][Full Text] [Related]
10. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
11. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
13. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
15. The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.
Bemelmans W; van Baal P; Wendel-Vos W; Schuit J; Feskens E; Ament A; Hoogenveen R
Prev Med; 2008 Feb; 46(2):127-32. PubMed ID: 17822752
[TBL] [Abstract][Full Text] [Related]
16. Resource allocation and health technology assessment in Australia: views from the local level.
Gallego G; van Gool K; Kelleher D
Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
[TBL] [Abstract][Full Text] [Related]
17. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
18. A comparison of parents and pediatric anesthesiologists' preferences for attributes of child daycase surgery: a discrete choice experiment.
Gidman W; Elliott R; Payne K; Meakin GH; Moore J
Paediatr Anaesth; 2007 Nov; 17(11):1043-52. PubMed ID: 17897269
[TBL] [Abstract][Full Text] [Related]
19. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices.
Elshaug AG; Hiller JE; Moss JR
Int J Technol Assess Health Care; 2008; 24(1):1-9. PubMed ID: 18218163
[TBL] [Abstract][Full Text] [Related]
20. Role of budget impact in drug reimbursement decisions.
Cohen JP; Stolk E; Niezen M
J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
